The UW Center for Human Genomics and Precision Medicine at the UW School of Medicine and Public Health recently opened its first patient clinic, the UW Undiagnosed Genetic Disease Clinic at the Waisman Center. The clinic, one of 11 specialty clinics at the Waisman Center, is for people with undiagnosed genetic diseases, creating a vital local hub in a global community of experts dedicated to solving medical mysteries with state-of-the-art technologies for people whose conditions remain undiagnosed despite an extensive prior clinical workup.
Could Alzheimer’s disease and schizophrenia be biologically connected? A new computational model, scGRNom (single-cell Gene Regulatory Network prediction from multi- omics), developed by researchers at the University of Wisconsin-Madison, harnesses the power of multi-omics and …
Español Padres e Hijos en Acción and the Waisman Center University Center for Excellence in Developmental Disabilities (UCEDD), University of Wisconsin-Madison announced a $330,000 grant to improve local health care responsiveness to the needs of …
Sousa is the second hire in the cluster initiative that includes a biostatistician, a neuroscientist, and a geneticist. The cluster will serve as a nucleus to integrate research, training, and clinical services in the human genomics research area at the Waisman Center. Waisman director Qiang Chang says he is very happy to have Sousa join the Waisman team.
A new study from the lab of Waisman investigator Xinyu Zhao, PhD, brings us one step closer to identifying treatments for psychiatric disorders like schizophrenia (SCZ) and illuminates the role of a specific gene in regulating the disorder. “Regulation of Cav3.2 by schizophrenia risk gene FXR1 is critical for interneuron functions and social behaviors” was published in the journal Molecular Psychiatry in April. The study also identifies a specific gene as the regulator of a type of neurons that plays a critical role in the pathogenesis of certain psychiatric disorders.
Pelin Cengiz, MD, an associate professor in the Department of Pediatrics and a Waisman Center investigator, is among this year’s recipients. She received the Chancellor’s Award for Excellence in Research: Independent Investigator.
Nell Maltman, PhD, a postdoctoral fellow in the Research in Neurodevelopmental Disabilities (RIDDL) Lab under the direction of Waisman investigator Audra Sterling, PhD, was among nine postdocs to receive an inaugural Postdoc Excellence Award.
In the shadow of the Fennimore water tower sits a nondescript metal building. The once-abandoned former feed mill has now become The Learning Center, a unique resource for youth with autism and their families. Therapy …
The Biden administration’s loosening of restrictions on the use of fetal tissue in research will allow UW-Madison scientists to continue such studies, which opponents have tried several times to ban in Wisconsin.
A new study from the lab of UW-Madison professor of medicine Luigi Puglielli, MD, PhD, opens a door to potential treatments for diseases of age, such as Alzheimer’s disease, by defining the roles of two enzymes that are imperative to protein production. “Endoplasmic reticulum acetyltransferases Atase1 and Atase2 differentially regulate reticulophagy, macroautophagy and cellular acetyl-CoA metabolism” was published in April in the journal Communications Biology.